– Sec Filing
BlackRock, TD SYNNEX And This Consumer Defensive Stock Insiders Are Selling
The Nasdaq Composite closed lower by around 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
Related Posts
Bristol Myers Squibb’s Stocks Falls on Q2 Miss, FY23 Forecast Cut As Two Of Its Top Drugs Face Generic Competition
Bristol Myers Squibb & Co (NYSE: BMY) said that its Q2 revenues of $11.23 billion declined 6% Y/Y, or 5% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line products and our new product portfolio.
Price Over Earnings Overview: HSBC Holdings
In the current session, the stock is trading at $39.38, after a 0.15% increase. Over the past month,…
